Literature DB >> 26184836

Serum paraoxonase activity is associated with epicardial fat tissue in renal transplant recipients.

Eray Eroglu1, Ismail Kocyigit, Aydin Unal, Hafsa Korkar, Cigdem Karakukcu, Ozcan Orscelik, Murat Hayri Sipahioglu, Bulent Tokgoz, Oktay Oymak.   

Abstract

AIMS: Cardiovascular disease is a major cause of mortality in renal transplant recipients. Paraoxonase-1 (PON-1) has been shown to protect against atherosclerosis by modifying lipoproteins. Epicardial fat tissue (EFT) has been proposed as a new cardiovascular risk factor. The aim of this study was to investigate the relationship between PON-1 activity and EFT in renal transplant recipients.
METHODS: Eighty renal transplant recipients were enrolled in this cross-sectional study. PON-1 activity was assessed from the rate of enzymatic hydrolysis of paraoxon to p-nitrophenol. EFT was measured by echocardiography.
RESULTS: The mean age of the patients was 40.4 ± 12.3 years and mean post transplant follow-up duration was 57.2 ± 46 months. Mean PON-1 activity was 68.5 ± 30 U/L. PON-1 activity was positively correlated with age and body mass index and negatively correlated with parathyroid hormone, dialysis duration and EFT. The mean EFT thickness was 0.64 ± 0.17 cm. Multiple linear regression analysis was used to define independent determinants of EFT in renal transplant recipients. According to linear regression analysis, PON-1 levels and age were found to be independent predictors of EFT.
CONCLUSION: Reduced PON-1 activity was negatively associated with EFT and PON-1 activity independently predicts EFT in renal transplant recipients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26184836     DOI: 10.1007/s11255-015-1051-8

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  38 in total

1.  Serum paraoxonase activity changes in uremic and kidney-transplanted patients.

Authors:  G Paragh; L Asztalos; I Seres; Z Balogh; L Löcsey; I Kárpáti; J Mátyus; E Katona; M Harangi; G Kakuk
Journal:  Nephron       Date:  1999       Impact factor: 2.847

2.  Injection of paraoxonase 1 (PON1) to mice stimulates their HDL and macrophage antiatherogenicity.

Authors:  Mira Rosenblat; Nina Volkova; Michael Aviram
Journal:  Biofactors       Date:  2011-12-08       Impact factor: 6.113

3.  Hybrid myocardial imaging for risk stratification prior to kidney transplantation: added value of coronary calcium and epicardial adipose tissue.

Authors:  Cristina Karohl; Luis D'Marco; Antonio Bellasi; Paolo Raggi
Journal:  J Nucl Cardiol       Date:  2013-09-12       Impact factor: 5.952

4.  Renal transplantation ameliorates the progression of arterial stiffness in patients treated with peritoneal dialysis.

Authors:  Tomasz Stompór; Marek Rajzer; Kalina Kawecka-Jaszcz; Aldona Dembińska-Kieć; Katarzyna Janda; Katarzyna Wójcik; Barbara Tabor; Anna Zdzienicka; Eve Janusz Grzybowska; Wladyslaw Sulowicz
Journal:  Perit Dial Int       Date:  2005 Sep-Oct       Impact factor: 1.756

5.  [Standardization Committee for Haematology. External Quality Assurance Program for General Hematology. Evaluation of the 1994 results].

Authors:  G Gutiérrez; J M Jou; J Carlos Reverter; F Martínez-Brotons; A Domingo; J Antonio Iriarte; A Remacha; J Rey; J L Vives Corrons
Journal:  Sangre (Barc)       Date:  1996-04

6.  Epicardial adipose tissue volume and cardiovascular disease in hemodialysis patients.

Authors:  Mehmet Nuri Turan; Ozkan Gungor; Gulay Asci; Fatih Kircelli; Turker Acar; Mustafa Yaprak; Naim Ceylan; Meltem Sezis Demirci; Selen Bayraktaroglu; Huseyin Toz; Mehmet Ozkahya; Ercan Ok
Journal:  Atherosclerosis       Date:  2012-11-06       Impact factor: 5.162

7.  Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction.

Authors:  Gianluca Iacobellis; Filippo Assael; Maria Cristina Ribaudo; Alessandra Zappaterreno; Giuseppe Alessi; Umberto Di Mario; Frida Leonetti
Journal:  Obes Res       Date:  2003-02

8.  Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients.

Authors:  O Hasselwander; D A Savage; D McMaster; C M Loughrey; P T McNamee; D Middleton; D P Nicholls; A P Maxwell; I S Young
Journal:  Kidney Int       Date:  1999-07       Impact factor: 10.612

Review 9.  Pharmacogenetics of paraoxonases: a brief review.

Authors:  D I Draganov; B N La Du
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-25       Impact factor: 3.000

10.  Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia.

Authors:  Jerzy Bełtowski; Grazyna Wójcicka; Anna Jamroz
Journal:  Atherosclerosis       Date:  2003-09       Impact factor: 5.162

View more
  1 in total

1.  Assessment of the relationship between serum paraoxonase activity and epicardial adipose tissue in hemodialysis patients.

Authors:  Emad Abdallah; Samya El-Shishtawy; Nevine Sherif; Ahmed Ali; Omnia El-Bendary
Journal:  Int Urol Nephrol       Date:  2016-11-23       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.